Timothy Moran - Motus GI CEO, Director

MOTSDelisted Stock  USD 0.65  0.02  2.99%   

CEO

Mr. Timothy P. Moran is Chief Executive Officer, Director of the Company. Prior to joining the Company, from 2015 to present, Mr. Moran served as President of the Americas, ConvaTec Group Plc, an international medical products and technologies company, offering products and services in the areas of wound and skin care, ostomy care, continence and critical care and infusion devices. Prior to his employment at ConvaTec, Mr. Moran held roles in sales, marketing and general management over the course of eighteen years at Coviden plc, an Irishheadquartered global health care products company and manufacturer of medical devices and supplies. While at Coviden, unitl 2015, Mr. Moran served simultaneously as VP and General Manager of both the SharpSafety and Monitoring Operating Room divisions. Following the 2015 acquisition of Covidien by Medtronic, Mr. Moran was named the Global Vice President and General Manager of the Patient Care and Safety Division. Mr. Moran also serves on the CEO Advisory Council for Advanced Medical Technology Association, a medical device trade association. Mr. Moran earned a B.A. in Organizational Communication at The State University of New York at Geneseo. Mr. Moran was selected as a director because of his broad commercial experience and leadership in the medical technology sector. since 2018.
Age 52
Tenure 6 years
Phone954 541 8000
Webhttps://www.motusgi.com

Timothy Moran Latest Insider Activity

Tracking and analyzing the buying and selling activities of Timothy Moran against Motus GI otc stock is an integral part of due diligence when investing in Motus GI. Timothy Moran insider activity provides valuable insight into whether Motus GI is net buyers or sellers over its current business cycle. Note, Motus GI insiders must abide by specific rules, including filing SEC forms every time they buy or sell Motus GI'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Motus GI Management Efficiency

The company has return on total asset (ROA) of (0.5985) % which means that it has lost $0.5985 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.5434) %, meaning that it created substantial loss on money invested by shareholders. Motus GI's management efficiency ratios could be used to measure how well Motus GI manages its routine affairs as well as how well it operates its assets and liabilities.
Motus GI Holdings currently holds 2.47 M in liabilities with Debt to Equity (D/E) ratio of 3.04, implying the company greatly relies on financing operations through barrowing. Motus GI Holdings has a current ratio of 4.19, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Motus GI until it has trouble settling it off, either with new capital or with free cash flow. So, Motus GI's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Motus GI Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Motus to invest in growth at high rates of return. When we think about Motus GI's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 2 records

CEO Age

Alex OvadiaCheck Cap
62
David DomzalskiVyne Therapeutics
57
Motus GI Holdings, Inc., a medical technology company, develops Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida. Motus Gi operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 30 people. Motus GI Holdings [MOTS] is traded as part of a regulated electronic over-the-counter service offered by the NASD. Motus GI is listed under Medical Equipment category by Fama And French industry classification.

Management Performance

Motus GI Holdings Leadership Team

Elected by the shareholders, the Motus GI's board of directors comprises two types of representatives: Motus GI inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Motus. The board's role is to monitor Motus GI's management team and ensure that shareholders' interests are well served. Motus GI's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Motus GI's outside directors are responsible for providing unbiased perspectives on the board's policies.
Elad Amor, Chief Officer
Mark Pomeranz, NonIndependent CEO
Timothy Moran, CEO, Director
Andrew MBA, Chief Officer
Scott Aldrich, VP Strategy
Ravit Ram, CFO Operations

Motus Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Motus GI a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Consideration for investing in Motus OTC Stock

If you are still planning to invest in Motus GI Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Motus GI's history and understand the potential risks before investing.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum